Thermococcus sp.B1001环糊精酶的重组表达及在麦芽七糖制备中的应用

成功构建pET-24a-tscd质粒,实现Thermococcus sp.Strain B1001来源的环糊精酶(TsCDase)在Es-cherichia coli BL21(DE3)中表达.通过热处理和镍柱分离对重组TsCDase进行纯化.酶学性质研究表明,重组TsCDase的比活为1 208.04 U/mg,最适温度为90℃、最适pH值为5.5.重组酶TsCDase在85℃、90℃、95℃条件下的半衰期分别为180、120、30min.酶转化研究表明,以80 g/L β-环糊精为底物,当酶转化温度为90℃、反应pH值为5.5～6.0,加酶量为25 U/g,反应时间为4 h时,麦芽七糖产率为81.19％和85.95％,七糖占产物麦芽寡糖的比例为95.24％和92.92％.本研究结果为工业化制备麦芽七糖奠定良好基础.     

中国人胎盘组织ABCB1基因多态性与P-gp表达水平的相关性

为了探讨中国人群胎盘组织中ABCB1基因单核苷酸多态性与其mRNA及蛋白表达水平的相关性,为妊娠期安全用药提供理论依据,本研究选取2016年6月至2018年5月于昆明医科大学第一附属医院正常分娩的200例中国汉族妇女的胎盘组织为研究对象,剪取母体侧胎盘组织,用于DNA、RNA和蛋白质的提取.通过测序确定ABCB1基因rs1045642、rs1128503及rs2032582多态性位点的基因型;采用实时荧光定量PCR和Western blot法测定组织中P-gp的mRNA和蛋白表达水平;对ABCB1基因多态性与P-gp的mRNA及蛋白表达水平的相关性进行分析.研究发现,对于rs1045642、rs1128503及rs2032582多态性位点,各基因型之间P-gp的mRNA及蛋白表达水平差异均无统计学意义(F=0.813,0.219,P＞0.05;F=0.132,0.086,P＞0.05;F=1.617,0.794,P＞0.05).本研究表明ABCB1 rs1045642、rs1128503及rs2032582基因多态性与中国汉族人群胎盘组织P-gp mRNA及蛋白表达水平可能无关.     

Application of germ-free NOD-scid IL2rgnull mice as a humanized model for tumor microbiome precision medicine

正In 2013, tumor immunotherapy topped the list of the top ten scientific breakthroughs(Couzin-Frankel, 2013), and it was widely used in the treatment of lung cancer, kidney cancer,and melanoma(Routy et al., 2018). However, the response rate of patients to tumor immunotherapy varies, and usually,only a small percentage of patients respond well to treatment(Sambi et al., 2019).     

Potassium and phosphorus transport and signaling in plants

Nitrogen(N), potassium(K), and phosphorus(P) are essential macronutrients for plant growth and development, and their availability affects crop yield. Compared with N, the relatively low availability of K and P in soils limits crop production and thus threatens food security and agricultural sustainability. Improvement of plant nutrient utilization efficiency provides a potential route to overcome the effects of K and P deficiencies. Investigation of the molecular mechanisms underlying how plants sense, absorb, transport, and use K and P is an important prerequisite to improve crop nutrient utilization efficiency. In this review, we summarize current understanding of K and P transport and signaling in plants, mainly taking Arabidopsis thaliana and rice(Oryza sativa) as examples. We also discuss the mechanisms coordinating transport of N and K, as well as P and N.     

家蝇Phormicin A多克隆抗体的制备及效价检测

家蝇Phormicin作为防御素家族的成员,是一类具有广普抗菌活性的抗菌肽.本研究采用原核表达法表达并纯化获得了家蝇PhormicinA蛋白.将家蝇Phormicin A原核表达蛋白与完全佐剂和不完全佐剂乳化混匀,先后免疫新西兰白兔获得其多克隆抗体.通过原核表达蛋白中和吸附实验,以及Western blot实验验证了抗体的特异性.进一步用金黄色葡萄球菌刺激家蝇三龄幼虫样品,进行内源性验证并测定抗体的效价.结果 显示,该多克隆抗体既可以识别家蝇Phormicin A原核表达蛋白,也可以识别金黄色葡萄球菌刺激家蝇三龄幼虫产生的内源性Phormicin A蛋白.本研究为进一步探索Phormicin在家蝇天然免疫和防御中的机制等后续工作打下基础.     

牦牛miR-383的靶基因预测及生物信息学分析

MicroRNAs (miRNAs)是一类非编码的小分子单链RNA,通过与靶基因的mRNA结合,抑制mRNA的翻译,参与多种生物学过程.本实验室前期通过高通量测序发现90日龄牦牛胚胎的背最长肌中miR-383的表达量显著高于成年牦牛.为探究miR-383在牦牛骨骼肌发育中的分子功能和机制,本研究对miR-383的靶基因进行预测,并进行生物信息学分析.通过TargetScan、miRDB和miRanda 3个软件预测了miR-383的靶基因,然后合并miRTarbase数据库中已被证实的靶基因作为基因集,分别用DAVID和KOBAS3.0在线软件对基因集进行功能注释(GO分析)和Pathway信号通路富集分析.结果 表明,牦牛miR-383序列在各物种间高度保守,靶基因功能富集于CD8阳性T细胞增殖的调控、核糖核蛋白复合物定位和负调控T细胞分化等生物学过程.信号通路分析发现靶基因的信号通路显著富集于PI3K-Ak、AMPK、FoxO和Focal adhesion等与肌肉发育相关的信号通路中.该研究结果将为miR-383功能及调控机制的深入研究提供参考依据,也为解析牦牛肌肉发育的分子机制提供新的研究方向.     

A botanical medicine dragon’s blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin

Deep vein thrombosis(DVT) is a common complication following traumatic fracture with a 0.5%–1% annual incidence. Low molecular weight heparin(LMWH) is the most commonly used anticoagulation drug for DVT prevention, but treatment with LMWH is invasive. Our aim is to compare the antithrombotic effect of dragon's blood, an oral botanical anticoagulant medicine approved by the Chinese FDA, with LMWH in patients undergoing hip fracture surgery and to explore the molecular mechanisms of anticoagulation treatment. Our study recruited patients and divided them into LMWH and dragon's blood treatment group. Coagulation index tests, Doppler ultrasound and m RNA sequencing were performed before and after anticoagulation therapy. There was no significant difference in postoperative DVT incidence between the two groups(23.1% versus 15.4%,P=0.694). D-dimer(D-D) and fibrinogen degradation product(FDP) showed significant reductions in both groups after anticoagulation treatments. We identified SLC4 A1, PROS1, PRKAR2 B and seven other genes as being differentially expressed during anticoagulation therapy in both groups. Genes correlated with coagulation indexes were also identified. Dragon's blood and LMWH showed similar effects on DVT and produced similar gene expression changes in patients undergoing hip fracture surgery, indicating that dragon's blood is a more convenient antithrombosis medicine(oral) than LMWH(hypodermic injection).     

A whole-genome association approach for large-scale interspecies traits

Science China Life Sciences -     

Adaptive T cell immunotherapy in cancer

Impaired tumor-specific effector T cells contribute to tumor progression and unfavorable clinical outcomes. As a compensatory T cell-dependent cancer immunoediting strategy, adoptive T cell therapy(ACT) has achieved encouraging therapeutic results,and this strategy is now on the center stage of cancer treatment and research. ACT involves the ex vivo stimulation and expansion of tumor-infiltrating lymphocytes(TILs) with inherent tumor reactivity or T cells that have been genetically modified to express the cognate chimeric antigen receptor or T cell receptor(CAR/TCR), followed by the passive transfer of these cells into a lymphodepleted host. Primed T cells must provide highly efficient and long-lasting immune defense against transformed cells during ACT. Anin-depth understanding of the basic mechanisms of these living drugs can help us improve upon current strategies and design better next-generation T cell-based immunotherapies. From this perspective, we provide an overview of current developments in different ACT strategies, with a focus on frontier clinical trials that offer a proof of principle. Meanwhile, insights into the determinants of ACT are discussed, which will lead to more rational, potent and widespread applications in the future.     

Marginal lands for bioenergy in China; an outlook in status,potential and management

Energy consumption and CO₂ emissions have been increasing continuously over the past few decades in China and there is a pressing need to replace the fossil fuel‐based economy with an efficient low‐carbon system, tailor‐made to future requirements. China is starting an energy transition with the aim of building an energy system for the future. China has made tremendous progress in increasing the amount of renewable energy and reducing the cost of renewable energy over the last 20 years. According to the 14th 5 year plan, China aims to incorporate 20% of renewable energy to the primary energy mix and attain 27% reduction in CO₂ emissions. Bioenergy crops constitute a significant proportion of biomass‐based bioenergy and have recently been promoted by the Chinese Government to help overcome food and fuel conflict. Steps are being taken to promote bioenergy crops on marginal lands in China, and various regions across the country with soil marginality have been evaluated for bioenergy crop cultivation. The present paper reviews the status of bioenergy in China and the potential status of marginal lands from different regions of China. It also elaborates on some of the policies, subsidies and incentives allocated by the Chinese Government for the promotion of biomass‐based energy. Land management and plant improvement strategies were discussed, which are effective in making marginal lands suitable for bioenergy crop cultivation. Managing planting strategies, intercropping and crop rotation are effective management practices used in China for the utilization of marginal lands. A national investigation is desirable for creating an inventory of technical and economic potential of biomass feedstocks that could be planted on marginal lands. This would assist with highlighting the pros and cons of using marginal lands for bioenergy production and effective policy making.